AXL and chronic myelogenous leukemia, BCR-ABL1 positive: Although AXL was first isolated and described as a potential oncogene in chronic myeloid leukemia (1, 2), it was later found to be overexpressed in solid tumors and numerous hematological cancers [reviewed in (6, 7, 52–54)].